Log In
Sunday 25th August 2019

Cambridge Antibody Technology

Cambridge Antibody Technology
Milstein Building
Granta Park
CB21 6GH

Tel: +44 (0)1223 471 471
Fax: +44 (0)1223 471 472
Email: info@cambridgeantibody.com
www: http://www.cambridgeantibody.com
Sub-category: Company - Pharmaceutical


Cambridge Antibody Technology (CAT) is a biopharmaceutical company committed to developing human monoclonal antibody therapeutics to bring improvements to seriously ill patients' lives.

In June 2006, CAT became part of the AstraZeneca group of companies – the acquisition of CAT by AstraZeneca representing a major long-term strategic investment by AstraZeneca in novel biological therapeutics. The AstraZeneca group intends to create a major R&D capability to deliver biological therapeutics with the new organisation led from CAT’s Cambridge base, and distinct from, but complementary to, the AstraZeneca Group’s small molecule capability.

Back to list of organisations

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019